Although chronic pain is one of the most important medical problems facing society, there has been very limited progress in the development of novel therapies for this condition. Here, we discuss high-impact research priorities to reduce the number of people transitioning from acute to chronic intractable pain.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The pain target NaV1.7 is expressed late during human iPS cell differentiation into sensory neurons as determined in high-resolution imaging
Pflügers Archiv - European Journal of Physiology Open Access 27 March 2024
-
NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice
Nature Communications Open Access 24 February 2024
-
Controlled activation of cortical astrocytes modulates neuropathic pain-like behaviour
Nature Communications Open Access 14 July 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ji, R. R., Chamessian, A. & Zhang, Y. Q. Science 354, 572–577 (2016).
Apkarian, A. V., Baliki, M. N. & Farmer, M. A. Curr. Opin. Neurol. 26, 360–367 (2013).
Denk, F., McMahon, S. B. & Tracey, I. Nat. Neurosci. 17, 192–200 (2014).
Skolnick, P. & Volkow, N. D. Neuron 92, 294–297 (2016).
Braz, J. M. et al. Neuron 74, 663–675 (2012).
Gewandter, J. S. et al. Pain 156, 1184–1197 (2015).
Acknowledgements
We thank the Interagency Pain Research Coordinating Committee of the US National Institutes of Health, who facilitated and provided financial support for meetings of the working group.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
RELATED LINKS
Federal Pain Research Strategy: https://iprcc.nih.gov/sites/default/files/iprcc/FPRS_Research_Recommendations_Final_508C.pdf
NIH policy: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-102.html
Supplementary information
Rights and permissions
About this article
Cite this article
Price, T.J., Basbaum, A.I., Bresnahan, J. et al. Transition to chronic pain: opportunities for novel therapeutics. Nat Rev Neurosci 19, 383–384 (2018). https://doi.org/10.1038/s41583-018-0012-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41583-018-0012-5
This article is cited by
-
NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice
Nature Communications (2024)
-
The pain target NaV1.7 is expressed late during human iPS cell differentiation into sensory neurons as determined in high-resolution imaging
Pflügers Archiv - European Journal of Physiology (2024)
-
Reengineering neurotechnology: placing patients first
Nature Mental Health (2023)
-
Specialized Microglia Resolve Neuropathic Pain in the Spinal Cord
Neuroscience Bulletin (2023)
-
Controlled activation of cortical astrocytes modulates neuropathic pain-like behaviour
Nature Communications (2022)